Characteristic

Screened and Tested,

N (%)

Screened but not Tested,

N (%)

Tested but not Screened,

N (%)

Not Screened or Tested,

N (%)

# Of cases, N (row %)

879 (9.9%)

5.748 (65%)

131 (1.5%)

2.123 (24%)

Days from pre-procedure negative test to procedure, median (IQR)

1.83 (1.00, 2.04)

1.92 (1.00, 2.08)

1.12 (0.71, 1.94)

1.92 (1.00, 2.12)

Days from procedure to post-procedure symptoms screen, median (IQR)

7.79 (5.98, 10.75)

8 (6.83, 10.92)

n/a

n/a

Days from procedure to post-procedure test, median (IQR)

9.88 (6.08, 11.96)

n/a

7.88 (6.75, 10.08)

n/a

Age (years), median (IQR)

65 (55, 73)

60 (49, 70)

68 (60, 76)

60 (48, 70)

Race/ethnicity

Hispanic-black

12 (1.4%)

86 (1.5%)

2 (1.5%)

35 (1.6%)

Hispanic-white

349 (40%)

2.402 (42%)

50 (38%)

885 (42%)

Non-hispanic-black

107 (12%)

726 (13%)

24 (18%)

275 (13%)

Non-hispanic-white

295 (34%)

1.651 (29%)

40 (31%)

622 (29%)

Other

32 (3.6%)

238 (4.1%)

7 (5.3%)

83 (3.9%)

Unknown

84 (9.6%)

645 (11%)

8 (6.1%)

223 (11%)

Female gender

461 (52%)

2.785 (48%)

63 (48%)

1.120 (53%)

Payer

Commercial

357 (41%)

2.780 (48%)

42 (32%)

1.059 (50%)

Government

29 (3.3%)

268 (4.7%)

1 (0.8%)

36 (1.7%)

Medicaid

63 (7.2%)

429 (7.5%)

8 (6.1%)

191 (9.0%)

Medicare

418 (48%)

2.110 (37%)

76 (58%)

807 (38%)

Other

12 (1.4%)

161 (2.8%)

4 (3.1%)

30 (1.4%)

Service line

Cardiology

34 (3.9%)

96 (1.7%)

8 (6.1%)

99 (4.7%)

Otolaryngologic surgery

36 (4.1%)

628 (11%)

10 (7.6%)

150 (7.1%)

Gastroenterology

149 (17%)

663 (12%)

35 (27%)

459 (22%)

General

13 (1.5%)

98 (1.7%)

7 (5.3%)

108 (5.1%)

Neurosurgery

29 (3.3%)

251 (4.4%)

13 (9.9%)

125 (5.9%)

Ophthalmology

459 (52%)

2.642 (46%)

10 (7.6%)

518 (24%)

Orthopaedic surgery

14 (1.6%)

239 (4.2%)

5 (3.8%)

84 (4.0%)

Surgical oncology

31 (3.5%)

194 (3.4%)

2 (1.5%)

97 (4.6%)

Urology

33 (3.8%)

281 (4.9%)

7 (5.3%)

145 (6.8%)

Other^a

81 (9.2%)

656 (11%)

34 (26%)

338 (16%)